Target intelligence / Profile preview

Atrial Natriuretic Factor Receptor B (NPR-B)

Target
NPR-B
Molecular classification
Receptor, Guanylyl Cyclase, Transmembrane Receptor
01

Overview

Atrial natriuretic factor receptor B, also known as natriuretic peptide receptor B (NPR-B) or NPR2, is a transmembrane receptor that primarily binds C-type natriuretic peptide (CNP). It is part of the guanylyl cyclase-coupled family of natriuretic peptide receptors. Upon binding its ligand, NPR-B catalyzes the conversion of GTP to cyclic GMP (cGMP), acting as a membrane-bound guanylyl cyclase. cGMP serves as a second messenger mediating downstream effects such as activation of cGMP-dependent protein kinases and modulation of ion channels. NPR-B plays a role in vasodilation, inhibition of vascular smooth muscle cell proliferation, regulation of atrial electrophysiology, and skeletal growth. Mutations in *NPR2* are associated with certain forms of skeletal dysplasia and may contribute to essential hypertension.

Other names
Natriuretic Peptide Receptor BGuanylyl Cyclase-BGC-BNPRBNPR2
02

Mechanism of action

Binding of CNP leading to activation of guanylyl cyclase and increased cGMP production.

03

Biological functions

Signal transductionVasodilationRegulation of vascular smooth muscle cell proliferationEndochondral ossificationRegulation of atrial electrophysiologycGMP production
04

Disease associations

Skeletal dysplasiaEssential hypertensionAtrial fibrillation
05

Safety considerations

Potential for altered vascular responses leading to blood pressure dysregulationDysregulation of calcium handling in cardiac myocytes

Beyond the preview

Go deeper on Atrial Natriuretic Factor Receptor B (NPR-B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atrial Natriuretic Factor Receptor B (NPR-B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call